APA (7th ed.) Citation

Keating, D., Marigowda, G., Burr, L., Daines, C., Mall, M. A., McKone, E. F., . . . Taylor-Cousar, J. L. (2018). VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. New England Journal of Medicine, 379(17), 1612. https://doi.org/10.1056/NEJMoa1807120

Chicago Style (17th ed.) Citation

Keating, Dominic, et al. "VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles." New England Journal of Medicine 379, no. 17 (2018): 1612. https://doi.org/10.1056/NEJMoa1807120.

MLA (9th ed.) Citation

Keating, Dominic, et al. "VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles." New England Journal of Medicine, vol. 379, no. 17, 2018, p. 1612, https://doi.org/10.1056/NEJMoa1807120.